Stock THAR THARIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Tharimmune, Inc.

Equities

THAR

US4327052001

Market Closed - Nasdaq
Other stock markets
 01:29:57 23/05/2024 am IST 		5-day change 1st Jan Change
0.326 USD -16.52% Intraday chart for Tharimmune, Inc. -10.59% -35.95%
04:40pm Tharimmune to Implement 1-for-15 Reverse Stock Split MT
09/05 Tharimmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Tharimmune, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2e4c35c.5imEHKsDhn6kxO8wXMLgeA-JL6O0xdv-emU8xD30QJg.sF7uRsRy6ReRj7ZCE7iJP0ewTNWZv6LTTRV-r1-kJqmsf9V5-2nIScWytg~866dc911e87eea5d769fc24a40f1564a

Analyst Recommendations on Tharimmune, Inc.

Dawson James Downgrades Hillstream BioPharma to Neutral From Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3905 USD
Average target price
5 USD
Spread / Average Target
+1,180.41%
High Price Target
5 USD
Spread / Highest target
+1,180.41%
Low Price Target
5 USD
Spread / Lowest Target
+1,180.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Tharimmune, Inc.

Dawson James

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. THAR Stock
  4. Consensus Tharimmune, Inc.